{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:57:57Z","timestamp":1784329077113,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T00:00:00Z","timestamp":1397260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s40261-014-0191-4","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T20:40:24Z","timestamp":1397248824000},"page":"431-435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Younger Females Are at Greater Risk of Vasodilation-Related Adverse Symptoms Caused by Dihydropyridine Calcium Channel Blockers: Results of a Study of 11,918 Japanese Patients"],"prefix":"10.1007","volume":"34","author":[{"given":"Ayami","family":"Kajiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Saruwatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Oniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoji","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Koda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seisuke","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,12]]},"reference":[{"issue":"1","key":"191_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/jhh.2011.112","volume":"27","author":"F Hadaegh","year":"2013","unstructured":"Hadaegh F, Mohebi R, Khalili D, et al. High normal blood pressure is an independent risk factor for cardiovascular disease among middle-aged but not in elderly populations: 9-year results of a population-based study. J Hum Hypertens. 2013;27(1):18\u201323.","journal-title":"J Hum Hypertens."},{"issue":"8","key":"191_CR2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/jwh.2011.2771","volume":"20","author":"P Palatini","year":"2011","unstructured":"Palatini P, Mos L, Santonastaso M, et al. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J Womens Health (Larchmt). 2011;20(8):1175\u201381.","journal-title":"J Womens Health (Larchmt)"},{"issue":"7","key":"191_CR3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/pds.554","volume":"9","author":"YS Kim","year":"2000","unstructured":"Kim YS, Park HS, Sunwoo S, et al. Short-term safety and tolerability of antihypertensive agents in Korean patients: an observational study. Pharmacoepidemiol Drug Saf. 2000;9(7):603\u20139.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"1","key":"191_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00202163","volume":"48","author":"K Kubota","year":"1995","unstructured":"Kubota K, Pearce GL, Inman WH. Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring. Eur J Clin Pharmacol. 1995;48(1):1\u20137.","journal-title":"Eur J Clin Pharmacol."},{"issue":"10","key":"191_CR5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40264-013-0077-z","volume":"36","author":"A Kajiwara","year":"2013","unstructured":"Kajiwara A, Saruwatari J, Sakata M, et al. Risk factors for adverse symptoms during dipeptidyl peptidase-IV inhibitor therapy: a questionnaire-based study carried out by the Japan Pharmaceutical Association Drug Event Monitoring project in Kumamoto Prefecture. Drug Saf. 2013;36(10):981\u20137.","journal-title":"Drug Saf."},{"issue":"9","key":"191_CR6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2165\/11538440-000000000-00000","volume":"30","author":"PM Silva da","year":"2010","unstructured":"da Silva PM. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine\/valsartan. Clin Drug Investig. 2010;30(9):625\u201341.","journal-title":"Clin Drug Investig."},{"issue":"6","key":"191_CR7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/sj.jhh.1001418","volume":"16","author":"E Degli Esposti","year":"2002","unstructured":"Degli Esposti E, Sturani A, Di Martino M, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens. 2002;16(6):439\u201344.","journal-title":"J Hum Hypertens."},{"issue":"6","key":"191_CR8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/jhh.2010.74","volume":"25","author":"RE Schmieder","year":"2011","unstructured":"Schmieder RE, Bohm M. Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients. J Hum Hypertens. 2011;25(6):354\u201363.","journal-title":"J Hum Hypertens."},{"issue":"8","key":"191_CR9","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ajh.2009.95","volume":"22","author":"MC Wong","year":"2009","unstructured":"Wong MC, Jiang JY, Griffiths SM. Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. Am J Hypertens. 2009;22(8):904\u201310.","journal-title":"Am J Hypertens."},{"issue":"5","key":"191_CR10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/jhh.2009.76","volume":"24","author":"M Thoenes","year":"2010","unstructured":"Thoenes M, Neuberger HR, Volpe M, et al. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J Hum Hypertens. 2010;24(5):336\u201344.","journal-title":"J Hum Hypertens."},{"issue":"6","key":"191_CR11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/jhh.2011.48","volume":"26","author":"DJ Trevisol","year":"2012","unstructured":"Trevisol DJ, Moreira LB, Fuchs FD, et al. Health-related quality of life is worse in individuals with hypertension under drug treatment: results of population-based study. J Hum Hypertens. 2012;26(6):374\u201380.","journal-title":"J Hum Hypertens."},{"issue":"1","key":"191_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12325-010-0002-0","volume":"27","author":"R Fogari","year":"2010","unstructured":"Fogari R, Malamani G, Corradi L, et al. Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients. Adv Ther. 2010;27(1):48\u201355.","journal-title":"Adv Ther."},{"issue":"16","key":"191_CR13","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1517\/14656566.2011.623698","volume":"12","author":"R Fogari","year":"2011","unstructured":"Fogari R, Zoppi A, Maffioli P, et al. Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients. Expert Opin Pharmacother. 2011;12(16):2441\u20138.","journal-title":"Expert Opin Pharmacother."},{"issue":"9","key":"191_CR14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/14656566.2011.580276","volume":"12","author":"R Fogari","year":"2011","unstructured":"Fogari R, Zoppi A, Mugellini A, et al. Effect of aliskiren addition to amlodipine on ankle edema in hypertensive patients: a three-way crossover study. Expert Opin Pharmacother. 2011;12(9):1351\u20138.","journal-title":"Expert Opin Pharmacother."},{"issue":"1","key":"191_CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/0044011-200929010-00002","volume":"29","author":"M Volpe","year":"2009","unstructured":"Volpe M, Brommer P, Haag U, et al. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study. Clin Drug Investig. 2009;29(1):11\u201325.","journal-title":"Clin Drug Investig."},{"issue":"2","key":"191_CR16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.36.2.270","volume":"36","author":"B Fisslthaler","year":"2000","unstructured":"Fisslthaler B, Hinsch N, Chataigneau T, et al. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension. 2000;36(2):270\u20135.","journal-title":"Hypertension."},{"issue":"3","key":"191_CR17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1677\/JOE-08-0070","volume":"197","author":"IC Villar","year":"2008","unstructured":"Villar IC, Hobbs AJ, Ahluwalia A. Sex differences in vascular function: implication of endothelium-derived hyperpolarizing factor. J Endocrinol. 2008;197(3):447\u201362.","journal-title":"J Endocrinol."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-014-0191-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-014-0191-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-014-0191-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:28:52Z","timestamp":1559503732000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-014-0191-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["191"],"URL":"https:\/\/doi.org\/10.1007\/s40261-014-0191-4","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,12]]}}}